Abraham Bassan

Insider Reports History

Location
C/O Graphite Bio, Inc., 279 East Grand Avenue, Suite 430, South San Francisco, CA
Signature
/s/ Svai Sanford, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Abraham Bassan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Rani Therapeutics Holdings, Inc. Director Stock Option (Right to Buy) 100K Oct 23, 2025 Direct
Graphite Bio, Inc. Director Stock Option (right to buy) 20K Jul 19, 2023 Direct
Septerna, Inc. Director Stock Option (Right to Buy) 16.6K Jun 17, 2025 Direct
CARGO Therapeutics, Inc. Director Stock Option (Right to Buy) 0 Aug 19, 2025 Direct

Insider Reports Filed by Abraham Bassan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RANI Rani Therapeutics Holdings, Inc. Oct 23, 2025 1 $0 4 Oct 27, 2025 Director
RANI Rani Therapeutics Holdings, Inc. Oct 23, 2025 0 $0 3 Oct 27, 2025 Director
CRGX CARGO Therapeutics, Inc. Aug 19, 2025 1 $0 4 Aug 19, 2025 Director
CRGX CARGO Therapeutics, Inc. Jun 18, 2025 1 $0 4 Jun 20, 2025 Director
SEPN Septerna, Inc. Jun 17, 2025 1 $0 4 Jun 20, 2025 Director
SEPN Septerna, Inc. Oct 24, 2024 0 $0 3 Oct 24, 2024 Director
CRGX CARGO Therapeutics, Inc. Jun 4, 2024 1 $0 4 Jun 6, 2024 Director
CRGX CARGO Therapeutics, Inc. Nov 9, 2023 1 $0 4 Nov 13, 2023 Director
CRGX CARGO Therapeutics, Inc. Nov 9, 2023 0 $0 3 Nov 9, 2023 Director
GRPH Graphite Bio, Inc. Jul 19, 2023 1 $0 4 Jul 21, 2023 Director
GRPH Graphite Bio, Inc. Jun 21, 2022 1 $0 4 Jun 22, 2022 Director
GRPH Graphite Bio, Inc. Jun 24, 2021 1 $0 4 Jun 28, 2021 Director
GRPH Graphite Bio, Inc. Jun 24, 2021 0 $0 3 Jun 24, 2021 Director